Jefferies says these are the best SMID-cap biotech stocks to buy
“Biotech is back,” says a recent Jefferies note, as new scientific breakthroughs and underpenetrated markets are unlocking a larger total ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
